During the past decade, Research Institute of Orlando conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Research Institute of Orlando" #1 sponsor was "Longboard Pharmaceuticals" with 2 trials, followed by "Amgen" with 1 trials sponsored, "Engage Therapeutics, Inc." with 1 trials sponsored, "LivaNova" with 1 trials sponsored and "Xenon Pharmaceuticals Inc." with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Research Institute of Orlando" #1 collaborator was "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Research Institute of Orlando" are "Developmental and Epileptic Encephalopathy" (2 trials), "Dravet Syndrome" (2 trials), "Epilepsy" (2 trials), "Drug Resistant Epilepsy" (1 trials) and "Focal Epilepsy" (1 trials). Many other conditions were trialed in "Research Institute of Orlando" in a lesser frequency.

Most popular intervention types in "Research Institute of Orlando" are "Drug" (5 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "LP352" (2 trials), "Erenumab" (1 trials), "Placebo" (1 trials), "Placebos" (1 trials) and "Staccato Alprazolam" (1 trials). Other intervention names were less common.

The vast majority of trials in "Research Institute of Orlando" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Research Institute of Orlando". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Research Institute of Orlando, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Research Institute of Orlando, 1 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".